Wypax and systemic inflammatory response syndrome Patient Reports February 09, 2010

Wypax Side Effects Report #5328417-1
Wypax side effect was reported by a Physician from JAPAN on Apr 26, 2007. Female patient, 22 years of age, was treated with Wypax. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood pressure decreased, bronchoalveolar lavage abnormal, lung disorder, somnolence, systemic inflammatory response syndrome, wheezing. Wypax dosage: 96 MG 1X ORAL. During the same period patient was treated with AMOXAN, VALPROATE, OLANZAPINE, ETHYL LOFLAZEPATE, ETIZOLAM, ANAFRANIL. Patient was hospitalized. Patient recovered.